BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 28409393)

  • 1. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
    Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
    Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
    Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
    J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
    Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
    Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigeminal neuropathy in vestibular schwannoma: a treatment algorithm to avoid long-term morbidity.
    Galloway L; Palaniappan N; Shone G; Hayhurst C
    Acta Neurochir (Wien); 2018 Apr; 160(4):681-688. PubMed ID: 29344779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis.
    Nguyen T; Duong C; Sheppard JP; Lee SJ; Kishan AU; Lee P; Tenn S; Chin R; Kaprealian TB; Yang I
    Clin Neurol Neurosurg; 2018 Mar; 166():116-123. PubMed ID: 29414150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.
    Meijer OW; Vandertop WP; Baayen JC; Slotman BJ
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1390-6. PubMed ID: 12873685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls.
    Carlson ML; Tveiten OV; Driscoll CL; Goplen FK; Neff BA; Pollock BE; Tombers NM; Castner ML; Finnkirk MK; Myrseth E; Pedersen PH; Lund-Johansen M; Link MJ
    J Neurosurg; 2015 Apr; 122(4):833-42. PubMed ID: 25555165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.
    Schneider T; Chapiro J; Lin M; Geschwind JF; Kleinberg L; Rigamonti D; Jusué-Torres I; Marciscano AE; Yousem DM
    Eur Radiol; 2016 Mar; 26(3):849-57. PubMed ID: 26139318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
    Söderlund Diaz L; Hallqvist A
    J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided stereotactic radiotherapy for patients with vestibular schwannoma. A clinical study.
    Badakhshi H; Muellner S; Wiener E; Budach V
    Strahlenther Onkol; 2014 Jun; 190(6):533-7. PubMed ID: 24589920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma knife radiosurgery in younger patients with vestibular schwannomas.
    Lobato-Polo J; Kondziolka D; Zorro O; Kano H; Flickinger JC; Lunsford LD
    Neurosurgery; 2009 Aug; 65(2):294-300; discussion 300-1. PubMed ID: 19625908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution.
    Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Sawangsilpa T; Janwityanujit T; Yongvithisatid P
    J Radiat Res; 2014 Mar; 55(2):351-8. PubMed ID: 24142966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
    Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.